Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma - PubMed (original) (raw)

Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma

Rudolf Reiter et al. Clin Cancer Res. 2006.

Abstract

Purpose: Aurora kinase A (AURKA/STK15/BTAK) encodes a serine/threonine kinase associated with chromosomal distribution and its up-regulation induces chromosomal instability, thereby leading to aneuploidy and cell transformation in several types of cancer. In this study, we investigated the role of AURKA in head and neck squamous cell carcinoma (HNSCC).

Experimental design: The mRNA expression levels of AURKA were compared in tumor tissues of 66 HNSCC patients with those in corresponding normal squamous epithelium by real-time quantitative reverse transcriptase-PCR. In addition, the association between AURKA mRNA and protein expression, centrosome abnormalities, and aneuploidy was studied in a subset of cases (n=34). All molecular variables were correlated to histomorphologic findings and clinical follow-up data of the patients.

Results: AURKA mRNA up-regulation was significantly associated with tumor stage and the occurrence of regional lymph node, as well as distant metastasis (P<0.0001 for all). Similarly, a correlation was found for protein expression and the occurrence of regional lymph node (P=0.0183) and distant metastasis (P=0.03). The mRNA was positively associated with protein expression (P=0.003) and centrosome abnormalities (P=0.03). Cox regression analysis revealed that AURKA mRNA up-regulation correlated with disease-free survival of the patients (P=0.03) as well as shorter overall survival (P<0.001).

Conclusions: We conclude that the up-regulation of AURKA mRNA may play a critical role in the tumor progression of HNSCC and provides useful information as a prognostic factor for HNSCC patients.

PubMed Disclaimer

Comment in

Aurora sheds light on head and neck squamous cell carcinoma.
Han H, Von Hoff DD. Han H, et al. Clin Cancer Res. 2006 Sep 1;12(17):5003-4. doi: 10.1158/1078-0432.CCR-06-1329. Clin Cancer Res. 2006. PMID: 16951211 Review. No abstract available.
Prognostic biomarkers in head and neck cancer.
Grandis JR. Grandis JR. Clin Cancer Res. 2006 Sep 1;12(17):5005-6. doi: 10.1158/1078-0432.CCR-06-1356. Clin Cancer Res. 2006. PMID: 16951212 Review. No abstract available.

Cited by

Somatic evolution of head and neck cancer - biological robustness and latent vulnerability.
Masuda M, Toh S, Wakasaki T, Suzui M, Joe AK. Masuda M, et al. Mol Oncol. 2013 Feb;7(1):14-28. doi: 10.1016/j.molonc.2012.10.009. Epub 2012 Nov 2. Mol Oncol. 2013. PMID: 23168041 Free PMC article. Review.
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies.
Siddiqi T, Frankel P, Beumer JH, Kiesel BF, Christner S, Ruel C, Song JY, Chen R, Kelly KR, Ailawadhi S, Kaesberg P, Popplewell L, Puverel S, Piekarz R, Forman SJ, Newman EM. Siddiqi T, et al. Leuk Lymphoma. 2020 Feb;61(2):309-317. doi: 10.1080/10428194.2019.1672052. Epub 2019 Oct 16. Leuk Lymphoma. 2020. PMID: 31617432 Free PMC article. Clinical Trial.
Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy.
Wang Y, Ji P, Liu J, Broaddus RR, Xue F, Zhang W. Wang Y, et al. Mol Cancer. 2009 Feb 13;8:8. doi: 10.1186/1476-4598-8-8. Mol Cancer. 2009. PMID: 19216791 Free PMC article. Review.
Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
Mazumdar A, Henderson YC, El-Naggar AK, Sen S, Clayman GL. Mazumdar A, et al. Head Neck. 2009 May;31(5):625-34. doi: 10.1002/hed.21007. Head Neck. 2009. PMID: 19107951 Free PMC article.
Prognosis value of mitotic kinase Aurora-A for primary duodenal adenocarcinoma.
Chen J, Lin Q, Wen JY, Li X, Ma XK, Fan XJ, Cao QH, Dong M, Wei L, Chen ZH, Li XY, Wang TT, Liu Q, Wan XB, Xing YF, Wu XY. Chen J, et al. Tumour Biol. 2014 Sep;35(9):9361-70. doi: 10.1007/s13277-014-2215-3. Epub 2014 Jun 20. Tumour Biol. 2014. PMID: 24943686

Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma - PubMed (original) (raw)